BACKGROUND: Coronary artery calcification (CAC) and metabolic syndrome (MS) have been associated with increased cardiovascular risk. The study objective was to examine the association of MS with CAC presence and progression in renal transplant recipients. METHODS: We measured the CAC progression in asymptomatic recipients who had no prior history of coronary artery disease. RESULTS: MS was common (55.4%). Median CAC scores were 0, 33.1, 98, and 261.9 for patients with one, two, three, and four or more positive components of the MS, respectively. Severe CAC scores were more common in recipients with MS (P=0.04). Although recipients with MS had higher mean CAC scores at baseline and significant CAC progression (483 [590.6] vs. 619 [813.8], P=0.01), MS was not an independent predictor of annualized rate of CAC change in a multivariate model. CONCLUSION: Future studies to evaluate if MS treatment improves cardiovascular outcomes are imperative.
BACKGROUND:Coronary artery calcification (CAC) and metabolic syndrome (MS) have been associated with increased cardiovascular risk. The study objective was to examine the association of MS with CAC presence and progression in renal transplant recipients. METHODS: We measured the CAC progression in asymptomatic recipients who had no prior history of coronary artery disease. RESULTS: MS was common (55.4%). Median CAC scores were 0, 33.1, 98, and 261.9 for patients with one, two, three, and four or more positive components of the MS, respectively. Severe CAC scores were more common in recipients with MS (P=0.04). Although recipients with MS had higher mean CAC scores at baseline and significant CAC progression (483 [590.6] vs. 619 [813.8], P=0.01), MS was not an independent predictor of annualized rate of CAC change in a multivariate model. CONCLUSION: Future studies to evaluate if MS treatment improves cardiovascular outcomes are imperative.
Authors: Shaista Malik; Nathan D Wong; Stanley S Franklin; Tripthi V Kamath; Gilbert J L'Italien; Jose R Pio; G Rhys Williams Journal: Circulation Date: 2004-08-23 Impact factor: 29.690
Authors: J M Díaz; Z Sainz; L L Guirado; F Ortiz-Herbener; M Picazo; R Garcia-Camin; J Palou; A Alcaraz; R Solà Journal: Transplant Proc Date: 2003-08 Impact factor: 1.066
Authors: Edward J Sharples; Divaka Pereira; Shaun Summers; John Cunningham; Michael Rubens; David Goldsmith; Muhammad M Yaqoob Journal: Am J Kidney Dis Date: 2004-02 Impact factor: 8.860
Authors: Aiko P J de Vries; Stephan J L Bakker; Willem J van Son; Jaap J Homan van der Heide; Rutger J Ploeg; Hauw T The; Paul E de Jong; Reinold O B Gans Journal: Am J Transplant Date: 2004-10 Impact factor: 8.086
Authors: Ali A Haydar; Nabil M A Hujairi; Adrian A Covic; Divaka Pereira; Michael Rubens; David J A Goldsmith Journal: Nephrol Dial Transplant Date: 2004-06-22 Impact factor: 5.992
Authors: María M Adeva-Andany; Carlos Fernández-Fernández; Lucía Adeva-Contreras; Natalia Carneiro-Freire; Alberto Domínguez-Montero; David Mouriño-Bayolo Journal: Curr Cardiol Rev Date: 2021
Authors: Isidor Minović; Michele F Eisenga; Ineke J Riphagen; Else van den Berg; Jenny Kootstra-Ros; Anne-Roos S Frenay; Harry van Goor; Gerald Rimbach; Tuba Esatbeyoglu; Andy P Levy; Carlo A J M Gaillard; Johanna M Geleijnse; Manfred L Eggersdorfer; Gerjan J Navis; Ido P Kema; Stephan J L Bakker Journal: Sci Rep Date: 2017-10-27 Impact factor: 4.379